Kara L. Davis
- Molecular Biology top 2%
- Immunology top 2%
- Oncology top 2%
- Biophysics top 0.2%
- Cancer Research top 5%
- Co-authors
- Garry P. NolanSean C. BendallErin F. SimondsDana Pe’erMichelle D. TadmorEl-ad David AmirJacob LevineSmita Krishnaswamy
- Topics
- CAR-T cell therapy research (30 papers)Acute Lymphoblastic Leukemia research (21 papers)Single-cell and spatial transcriptomics (15 papers)
- Partner nations
- United StatesItalyIsrael
In The Last Decade
Kara L. Davis
67 papers receiving 4.4k citations
Hit Papers
Peers
Comparison fields: 5 of 142
- Molecular Biology 2.6k
- Immunology 1.4k
- Oncology 1.0k
- Biophysics 748
- Cancer Research 431
Countries citing papers authored by Kara L. Davis
This map shows the geographic impact of Kara L. Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kara L. Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kara L. Davis more than expected).
Fields of papers citing papers by Kara L. Davis
This network shows the impact of papers produced by Kara L. Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kara L. Davis. The network helps show where Kara L. Davis may publish in the future.
Co-authorship network of co-authors of Kara L. Davis
This figure shows the co-authorship network connecting the top 25 collaborators of Kara L. Davis. A scholar is included among the top collaborators of Kara L. Davis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kara L. Davis. Kara L. Davis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 0 | |
| 5 | 1 | |
| 6 | 2 | |
| 7 | 5 | |
| 8 | 43 | |
| 9 | 2 | |
| 10 | 6 | |
| 11 | 17 | |
| 12 | 49 | |
| 13 | 25 | |
| 14 | 0 | |
| 15 | 35 | |
| 16 | 1 | |
| 17 | 85 | |
| 18 | 81 | |
| 19 | Data-Driven Phenotypic Dissection of AML Reveals Progenitor-like Cells that Correlate with Prognosisbreakdown → | 1279 |
| 20 | 13 |
About Kara L. Davis
Kara L. Davis is a scholar working on Hematology, Biophysics and Oncology, having authored 74 papers that have together received 4.4k indexed citations. Recurring topics across this work include CAR-T cell therapy research (30 papers), Acute Lymphoblastic Leukemia research (21 papers) and Single-cell and spatial transcriptomics (15 papers). The work is most often cited by research in Biophysics (748 citations), Immunology (1.4k citations) and Molecular Biology (2.6k citations). Kara L. Davis has collaborated with scholars based in United States, Italy and Israel. Frequent co-authors include Garry P. Nolan, Sean C. Bendall, Erin F. Simonds, Dana Pe’er, Michelle D. Tadmor, El-ad David Amir, Jacob Levine, Smita Krishnaswamy, Astraea Jager and Harris G. Fienberg. Their work appears in journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.